“evelo-biosciences” Archives

in
Entry Author Date Location
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Flagship Pioneering Unveils Kintai’s Gut Approach to Treating Disease 04/16/19 Boston
Flagship Reloads With $824M For Latest Growth Capital Fund 03/20/19 Boston
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Kaleido Bio Downsizes IPO, Raises $75M for Microbiome Drug Tests 02/27/19 Boston
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer 05/09/18 Boston
Boston VC Continues Surge in Q1; Here are the Top 10 Deals 04/11/18 Boston
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
Akili, Emulate, Ginkgo & More: The Innovation at the Intersection Award Finalists 09/18/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Evelo Bio Raises $50M Round to Bring Microbiome Drugs Into Trials 07/11/17 Boston
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Page 1 of 1